IP
PHIO icon

Intellectus Partners’s Phio Pharmaceuticals PHIO Stock Holding History

Intellectus Partners’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$9K – 440
2018
Q3 		$9K Sell
1
-1
-50% -$9.41K ﹤0.01% 484
2018
Q2 		$19K Buy
2
+1
+100% +$14.8K 0.01% 433
2018
Q1 		$16K Buy
+1
New +$23K 0.01% 442
2017
Q4 		– Hold
0
– – – 475

Other funds holding PHIO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Intellectus Partners's PHIO Position: Q4 2018 in Review

Intellectus Partners sold out of Phio Pharmaceuticals (PHIO) in Q4 2018, closing a stake of 1 share — an estimated $9K sold.

Intellectus Partners first reported a position in PHIO in Q1 2018 and held it in 3 quarters. The position peaked at $19K in Q2 2018. 7 funds tracked by Wall St. Rank hold PHIO as of Q4 2018.

  • Intellectus Partners reported no remaining Phio Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 1 Phio Pharmaceuticals share in Q4 2018, an estimated $9K.
  • Intellectus Partners first reported a position in Phio Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Intellectus Partners's Phio Pharmaceuticals position peaked at $19K in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.